_Federico_Caputo_Alamy.jpg?#)
At Current Prices GLP-1s Aren’t Cost-Effective, Limiting Access To Patients
GLP-1s can deliver value to patients. But the fact that GLP-1s aren't cost-effective at their current net prices can limit insurer coverage and prevent equitable access.
GLP-1s can deliver value to patients. But the fact that GLP-1s aren't cost-effective at their current net prices can limit insurer coverage and prevent equitable access.
